Meghan Hill is currently a 4th year PhD student in the lab of Taeho Kim, based out of the Institute for Quantitative Health Science and Engineering. Her research is focused on developing new nanoparticle systems that can be used for early diagnosis and treatment of brain cancers. Meghan came to our attention after she recently placed 1st in the MSU 3-minute thesis competition and competed at the Midwest regional 3-minute competition in Chicago.

Before attending MSU, Meghan Hill completed internships with Los Alamos National Laboratory and the National Center for Genome Resources. In May 2019, she completed a Bachelor of Science in chemical engineering with a double minor in biology and biomedical engineering at New Mexico Tech. While pursuing her undergraduate degree, she did research under Dr. Michealann Tartis and Dr. Liliya Frolova in synthesizing new prodrugs for targeted drug delivery using liposomes.

In August of 2019, she joined the Biomedical Engineering department at Michigan State University to pursue her PhD. The College of Engineering at MSU awarded her a dissertation completion fellowship for spring 2023. Her planned defense date is January 2024 with her expected graduation in May of 2024. After graduation, she plans to join the pharmaceutical industry in hopes to help develop new medical technologies that can be translated into the clinic. As of right now she has 5 co-author paper (4 out of MSU) and is currently working on a first author manuscript based on the work presented to the board.